SureTrader SureTrader
Home > Boards > Free Zone > Health and Sciences >

Biotech Values

RSS Feed
      Hide Sticky   Hide Intro
Moderator: DewDiligence Assistants: Biowatch
Search This Board:
Last Post: 12/8/2016 10:34:50 PM - Followers: 1310 - Board type: Free - Posts Today: 0

Biotech Values is a forum for discussing 
all facets of biotech investing with an emphasis
on fundamental analysis and avoiding scams.
We generally do not discuss microcap stocks.

Calendars and Compilations
Webcasts
Recent Biotech Buyouts
Buyouts of Biotech Partners
FoB Collaborations

Common Biotech-Newbie Mistakes
Biotech Holdings of Selected Institutional Investors
US Patent Expirations for Big-Selling Biologics
Biotech and Miscellaneous Acronyms

Top Twitter Feeds for Biotech Info
iHub's Greatest Hits (thru 5/09)

PostSubject
#206796  Sticky Note BIIB’s PR on (leaked) Aducanumab data from CTAD: DewDiligence 12/08/16 07:51:16 PM
#206774  Sticky Note GILD submits NDA for SOF/VEL/VOX HCV regimen as DewDiligence 12/08/16 10:13:09 AM
#206770  Sticky Note SGEN Adcetris is definitely more active in HL, but dewophile 12/08/16 09:25:12 AM
#206765  Sticky Note VYGR: Here is a link to the slides: ghmm 12/08/16 07:08:23 AM
#206741  Sticky Note existing FDA staffers will presumably have a lot iwfal 12/07/16 03:53:30 PM
#206729  Sticky Note FDA President-elect Donald Trump’s transition team is considering a WorstLuck 12/07/16 01:54:15 PM
#206800   XTNT Price targets just raised to two dollars plus UHD 12/08/16 10:34:50 PM
#206799   FWIW: Trump FDA canidate: Jim O'Neill https://www.statnews.com/2016/12/07/trump-fda-oneill/ greenehugh 12/08/16 09:01:55 PM
#206798   EPVantage comments on ASH winners/losers: DewDiligence 12/08/16 07:56:27 PM
#206797   Nice. You beat me to post by 1 minute! puravida 12/08/16 07:53:24 PM
#206796   BIIB’s PR on (leaked) Aducanumab data from CTAD: DewDiligence 12/08/16 07:51:16 PM
#206795   BMY raises quarterly dividend by a penny: DewDiligence 12/08/16 07:48:07 PM
#206794   MYL cutting 3,000 jobs—9% of global workforce: DewDiligence 12/08/16 07:47:16 PM
#206793   MYL obtains IPRs on several Restatis patents: DewDiligence 12/08/16 07:43:26 PM
#206792   I really don't think you need anything more biomaven0 12/08/16 05:02:57 PM
#206791   CTAD conference. Not CNAD. LOL puravida 12/08/16 04:44:07 PM
#206790   BIIB's Alzheimer's data leak out of CNAT San puravida 12/08/16 04:42:49 PM
#206789   If your theory was correct, there should be zipjet 12/08/16 04:34:48 PM
#206788   >>That increases the FCF and value of those biomaven0 12/08/16 04:23:43 PM
#206787   Another reason for bios under performance, not clearly zipjet 12/08/16 03:36:44 PM
#206786   yes but I figured I would post here dewophile 12/08/16 02:35:20 PM
#206785   Biomaven addressed this pretty well on Twitter ronpopeil 12/08/16 02:28:42 PM
#206784   relevant to TRIL - i came across this dewophile 12/08/16 02:19:52 PM
#206783   Why Biotech is Getting Killed…And Why It Will Titan V 12/08/16 01:50:40 PM
#206782   Pharmaceutical Executives Charged in Racketeering Scheme jbog 12/08/16 01:47:15 PM
#206781   PRTO: I think we're talking past each other at poorgradstudent 12/08/16 12:32:42 PM
#206780   Top of 2017's pharma heap? Pfizer, Novartis, Roche—and jbog 12/08/16 12:28:24 PM
#206779   Jenkins' retirement is not a consequence of the DewDiligence 12/08/16 10:32:42 AM
#206778   HZNP -19% on Actimmune failure in Friedreich's ataxia: DewDiligence 12/08/16 10:31:24 AM
#206777   Jenkins announced retirement, effective during 1st week of north40000 12/08/16 10:31:23 AM
#206776   The only direct quote pertaining to drug prices DewDiligence 12/08/16 10:23:17 AM
#206775   https://www.bloomberg.com/news/articles/2016-12-07/trump-says-he-ll-bring-down-d north40000 12/08/16 10:19:19 AM
#206774   GILD submits NDA for SOF/VEL/VOX HCV regimen as DewDiligence 12/08/16 10:13:09 AM
#206773   PBYI -9% on updates from SABC: DewDiligence 12/08/16 10:01:16 AM
#206772   OHRP -29% on warrant-laden financing: DewDiligence 12/08/16 09:52:44 AM
#206770   SGEN Adcetris is definitely more active in HL, but dewophile 12/08/16 09:25:12 AM
#206769   So you're saying the average cost of developing DewDiligence 12/08/16 09:20:04 AM
#206768   MMM = thousand cubed or billion (not to GrthzGd 12/08/16 08:50:00 AM
#206767   BPMC sells 5.75M* shares @$25.00—a 12% discount to zipjet 12/08/16 08:13:53 AM
#206766   ContraVir's Cyclophilin Inhibitor CRV431 Potently Inhibits Essential Pathway Giovanni 12/08/16 08:08:32 AM
#206765   VYGR: Here is a link to the slides: ghmm 12/08/16 07:08:23 AM
#206764   Keep Politics Out of Drug Approval n4807g 12/08/16 06:50:13 AM
#206763   Cancer Breakthrough Aids One Patient, Raises Hopes for Many Titan V 12/07/16 11:32:42 PM
#206762   Boston Biotech Conferences: East / West CEO Conference Titan V 12/07/16 11:23:21 PM
#206761   My guess is this stuff happening (new bill Jonathan Robinson 12/07/16 10:55:48 PM
#206760   Today was a terrible day for the drug jbog 12/07/16 07:59:00 PM
#206759   [OT]—VMATX rose almost 1% today, which is ~40%(!) DewDiligence 12/07/16 07:56:31 PM
#206758   That tweet got hardly any notice, even as iwfal 12/07/16 07:43:44 PM
#206757   BPMC sells 5.75M* shares @$25.00—a 12% discount to DewDiligence 12/07/16 07:34:24 PM
#206756   ...an untenable mess of unintended consequences... Probably true DewDiligence 12/07/16 07:28:12 PM
#206755   ...[safety and efficacy are] joined at the hip, DewDiligence 12/07/16 07:23:29 PM
#206754   VYGR +40%/AH on phase-1b data in PD: DewDiligence 12/07/16 07:09:17 PM
#206753   my point was that drugs would still have OakesCS 12/07/16 06:28:46 PM
#206752   180-day launch delay for FoBs likely heading to DewDiligence 12/07/16 05:54:58 PM
#206751   Achillion’s patent application published Oct. 2014 indicates ACH dangerM 12/07/16 05:54:04 PM
#206750   I have great faith in liability lawyers' DewDiligence 12/07/16 05:43:14 PM
PostSubject